Nat Gene:采用GWAS方法发现中风相关的遗传基因HDAC9

2012-03-08 MedSci MedSci原创

3月8日,国际著名杂志Nature Genetics在线刊登了德国、英国等国家研究人员的最新研究成果“Genome- wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke”,在这篇研究报告中,研究者揭示了中风的易感性与若干遗传变异有关。 作为成人慢性致死疾

3月8日,国际著名杂志Nature Genetics在线刊登了德国、英国等国家研究人员的最新研究成果“Genome- wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke”,在这篇研究报告中,研究者揭示了中风的易感性与若干遗传变异有关。

作为成人慢性致死疾病的一种重要病因,中风逐渐成为全球关注的公共健康问题。世界上约有80%的中风属于缺血性中风——因血液供应不畅所致。其中,缺血性中风又包含三种常见子类型:大血管中风、心因性脑梗塞中风和小血管中风。

研究者Hugh Markus和同事使用全基因组关联分析手段,对具有欧洲血统的3548例缺血性中风病患以及5972例对照组进行研究,并通过临床评估,脑部和血管成像方法将患者进行子类型分类,他们鉴别出了一个与大血管中风有关的基因区域,其中包括一个名为HDAC9的基因,该基因可对组蛋白去乙酰化酶蛋白进行编码。同时,研究小组还复制出了三个已报道过的相关基因区域,他们发现这四个基因区域在中风的子类型中表现出异质性,这意味着中风子类型的发病机制并不相同。

Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke

The International Stroke Genetics Consortium (ISGC), the Wellcome Trust Case Control Consortium 2 (WTCCC2), Céline Bellenguez, Steve Bevan, Andreas Gschwendtner, Chris C A Spencer, Annette I Burgess, Matti Pirinen, Caroline A Jackson, Matthew Traylor, Amy Strange, Zhan Su, Gavin Band, Paul D Syme, Rainer Malik, Joanna Pera, Bo Norrving, Robin Lemmens, Colin Freeman, Renata Schanz, Tom James, Deborah Poole, Lee Murphy, Helen Segal, Lynelle Cortellini, Yu-Ching Cheng, Daniel Woo, Michael A Nalls, Bertram Müller-Myhsok, Christa Meisinger, Udo Seedorf, Helen Ross-Adams, Steven Boonen, Dorota Wloch-Kopec, Valerie Valant, Julia Slark, Karen Furie, Hossein Delavaran, Cordelia Langford, Panos Deloukas, Sarah Edkins, Sarah Hunt, Emma Gray, Serge Dronov, Leena Peltonen, Solveig Gretarsdottir, Gudmar Thorleifsson, Unnur Thorsteinsdottir, Kari Stefansson, Giorgio B Boncoraglio, Eugenio A Parati, John Attia, Elizabeth Holliday, Chris Levi, Maria-Grazia Franzosi, Anuj Goel, Anna Helgadottir, Jenefer M Blackwell, Elvira Bramon, Matthew A Brown, Juan P Casas, Aiden Corvin, Audrey Duncanson, Janusz Jankowski, Christopher G Mathew, Colin N A Palmer, Robert Plomin, Anna Rautanen, Stephen J Sawcer, Richard C Trembath, Ananth C Viswanathan, Nicholas W Wood, Bradford B Worrall, Steven J Kittner, Braxton D Mitchell, Brett Kissela, James F Meschia, Vincent Thijs, Arne Lindgren, Mary Joan Macleod, Agnieszka Slowik, Matthew Walters, Jonathan Rosand, Pankaj Sharma, Martin Farrall, Cathie L M Sudlow, Peter M Rothwell, Martin Dichgans, Peter Donnelly & Hugh S Markus

Genetic factors have been implicated in stroke risk, but few replicated associations have been reported. We conducted a genome-wide association study (GWAS) for ischemic stroke and its subtypes in 3,548 affected individuals and 5,972 controls, all of European ancestry. Replication of potential signals was performed in 5,859 affected individuals and 6,281 controls. We replicated previous associations for cardioembolic stroke near PITX2 and ZFHX3 and for large vessel stroke at a 9p21 locus. We identified a new association for large vessel stroke within HDAC9 (encoding histone deacetylase 9) on chromosome 7p21.1 (including further replication in an additional 735 affected individuals and 28,583 controls) (rs11984041; combined P = 1.87 × 10−11; odds ratio (OR) = 1.42, 95% confidence interval (CI) = 1.28–1.57). All four loci exhibited evidence for heterogeneity of effect across the stroke subtypes, with some and possibly all affecting risk for only one subtype. This suggests distinct genetic architectures for different stroke subtypes.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2048422, encodeId=c2b32048422ee, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Jun 23 11:43:00 CST 2012, time=2012-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2003397, encodeId=757b200339e5b, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8593, encryptionId=86d585931d, topicName=HDAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Sun Sep 30 18:43:00 CST 2012, time=2012-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879146, encodeId=6d5318e9146fe, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Jul 21 09:43:00 CST 2012, time=2012-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280021, encodeId=c61612800213f, content=<a href='/topic/show?id=b05983454a' target=_blank style='color:#2F92EE;'>#GWAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8345, encryptionId=b05983454a, topicName=GWAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Sat Mar 10 13:43:00 CST 2012, time=2012-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579590, encodeId=bff715e9590cb, content=<a href='/topic/show?id=f9dc95080f6' target=_blank style='color:#2F92EE;'>#遗传基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95080, encryptionId=f9dc95080f6, topicName=遗传基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7816540807, createdName=陆成振, createdTime=Sat Mar 10 13:43:00 CST 2012, time=2012-03-10, status=1, ipAttribution=)]
    2012-06-23 cy0324
  2. [GetPortalCommentsPageByObjectIdResponse(id=2048422, encodeId=c2b32048422ee, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Jun 23 11:43:00 CST 2012, time=2012-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2003397, encodeId=757b200339e5b, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8593, encryptionId=86d585931d, topicName=HDAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Sun Sep 30 18:43:00 CST 2012, time=2012-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879146, encodeId=6d5318e9146fe, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Jul 21 09:43:00 CST 2012, time=2012-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280021, encodeId=c61612800213f, content=<a href='/topic/show?id=b05983454a' target=_blank style='color:#2F92EE;'>#GWAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8345, encryptionId=b05983454a, topicName=GWAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Sat Mar 10 13:43:00 CST 2012, time=2012-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579590, encodeId=bff715e9590cb, content=<a href='/topic/show?id=f9dc95080f6' target=_blank style='color:#2F92EE;'>#遗传基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95080, encryptionId=f9dc95080f6, topicName=遗传基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7816540807, createdName=陆成振, createdTime=Sat Mar 10 13:43:00 CST 2012, time=2012-03-10, status=1, ipAttribution=)]
    2012-09-30 lingaifan
  3. [GetPortalCommentsPageByObjectIdResponse(id=2048422, encodeId=c2b32048422ee, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Jun 23 11:43:00 CST 2012, time=2012-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2003397, encodeId=757b200339e5b, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8593, encryptionId=86d585931d, topicName=HDAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Sun Sep 30 18:43:00 CST 2012, time=2012-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879146, encodeId=6d5318e9146fe, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Jul 21 09:43:00 CST 2012, time=2012-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280021, encodeId=c61612800213f, content=<a href='/topic/show?id=b05983454a' target=_blank style='color:#2F92EE;'>#GWAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8345, encryptionId=b05983454a, topicName=GWAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Sat Mar 10 13:43:00 CST 2012, time=2012-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579590, encodeId=bff715e9590cb, content=<a href='/topic/show?id=f9dc95080f6' target=_blank style='color:#2F92EE;'>#遗传基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95080, encryptionId=f9dc95080f6, topicName=遗传基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7816540807, createdName=陆成振, createdTime=Sat Mar 10 13:43:00 CST 2012, time=2012-03-10, status=1, ipAttribution=)]
    2012-07-21 liye789132251
  4. [GetPortalCommentsPageByObjectIdResponse(id=2048422, encodeId=c2b32048422ee, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Jun 23 11:43:00 CST 2012, time=2012-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2003397, encodeId=757b200339e5b, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8593, encryptionId=86d585931d, topicName=HDAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Sun Sep 30 18:43:00 CST 2012, time=2012-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879146, encodeId=6d5318e9146fe, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Jul 21 09:43:00 CST 2012, time=2012-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280021, encodeId=c61612800213f, content=<a href='/topic/show?id=b05983454a' target=_blank style='color:#2F92EE;'>#GWAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8345, encryptionId=b05983454a, topicName=GWAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Sat Mar 10 13:43:00 CST 2012, time=2012-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579590, encodeId=bff715e9590cb, content=<a href='/topic/show?id=f9dc95080f6' target=_blank style='color:#2F92EE;'>#遗传基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95080, encryptionId=f9dc95080f6, topicName=遗传基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7816540807, createdName=陆成振, createdTime=Sat Mar 10 13:43:00 CST 2012, time=2012-03-10, status=1, ipAttribution=)]
    2012-03-10 lxg951
  5. [GetPortalCommentsPageByObjectIdResponse(id=2048422, encodeId=c2b32048422ee, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Jun 23 11:43:00 CST 2012, time=2012-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2003397, encodeId=757b200339e5b, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8593, encryptionId=86d585931d, topicName=HDAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Sun Sep 30 18:43:00 CST 2012, time=2012-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879146, encodeId=6d5318e9146fe, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Jul 21 09:43:00 CST 2012, time=2012-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280021, encodeId=c61612800213f, content=<a href='/topic/show?id=b05983454a' target=_blank style='color:#2F92EE;'>#GWAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8345, encryptionId=b05983454a, topicName=GWAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Sat Mar 10 13:43:00 CST 2012, time=2012-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579590, encodeId=bff715e9590cb, content=<a href='/topic/show?id=f9dc95080f6' target=_blank style='color:#2F92EE;'>#遗传基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95080, encryptionId=f9dc95080f6, topicName=遗传基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7816540807, createdName=陆成振, createdTime=Sat Mar 10 13:43:00 CST 2012, time=2012-03-10, status=1, ipAttribution=)]

相关资讯

Brain:英科学家发现用电流刺激大脑有助治疗中风

最近一项最新研究显示,对因中风而丧失部分行动能力的患者来说,如果使用微弱电流刺激大脑中的特定部位,可以帮助他们改善行动能力。 英国牛津大学等机构的研究人员在英国新一期《脑》(Brain)杂志上报告说,他们请一些中风患者参与了电流刺激试验。这些患者年龄在30岁到80岁之间,男女都有,中风类型多样,但都在接受电流刺激后出现了行动能力改善的现象。 在试验中,患者大脑特定部位被贴上电极

Neurology:DRAGON评分方法有助医生决定对中风者采取何种措施

阿替普酶属机体抗凝血因子,能结合到血纤维蛋白上,激活纤维蛋白酶原,使其转化成血纤维蛋白酶,继而溶解血纤维蛋白,使血栓得以溶解。临床上主要用于治疗急性心肌梗塞。 近日,Neurology杂志上的刊登的一项表明:研究人员成功开发的一种新的评分方法可以帮助临床医生快速判断阿替普酶对哪种类型的中风症有效,这种名叫DRAGON的简单、快速且免费的评分方法具有86%的准确率。 共有1,319名接受阿替普酶

JAMA:外科手术不能降低小中风后续风险

《美国医学会杂志》(JAMA)在11月9日刊的一则研究披露,在颈内动脉(为脑供血的动脉)增厚和堵塞的病人中及在那些有血液动力性脑缺血(脑血流量不足,中风的亚型)的病人中,那些用外科手术来改善动脉血流的患者在术后2年的时候与那些仅接受内科治疗的类似病人相比,其中风发生率没有减少。 根据文章的背景资料:“动脉粥样硬化性颈动脉闭塞(AICAO)会引起约10%的短暂性脑缺血发作[ TIAs,部分脑子